EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating the Association of Ki-67 with Oncotype DX Recurrence Score in Early-Stage ER-Positive/HER2-Negative Breast Cancer

Dimitrios Dragoumis, George Kapetsis, Konstantinos Louis iD, Dimitrios Maniatis, Eleni Mpalampou, Konstantinos Bouloukos, Xenophon Xenakis iD, Nikolaos Papaioannou, Styliani Parpoudi, Grigorios Pesmatzoglou, Anna Sachoulidou iD, Eleftherios Sfakianakis und 16 weitere

Cancers · 26.05.2026 · 18 (11) · 1731

DOI: 10.3390/cancers18111731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 26.05.2026. Verfasst von Dimitrios Dragoumis und 27 weiteren Autor:innen. Beteiligte Einrichtung: Breast Division, Department of General Surgery, St. Luke's Hospital, Panorama, 55236 Thessaloniki, Greece. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Ki-67 is widely used as an immunohistochemical marker of tumor proliferation in hormone receptor-positive (HR-positive), HER2-negative breast cancer, but its interpretation is limited by variability and uncertain concordance with genomic assays. The Oncotype DX® Recurrence Score (RS) is a validated multigene assay with established prognostic and predictive utility. This study evaluated the relationship between Ki-67 and RS in clinical practice. Methods: We retrospectively analyzed women in Greece with early-stage estrogen receptor-positive, HER2-negative breast cancer without distant metastasis (pM0) who underwent Oncotype DX testing between 2020 and 2023. Eligible patients were node-negative or postmenopausal with node-positive disease. RS was categorized as low (0–25) or high (>25). Ki-67 was assessed using binary (5–

Schlagwörter

Stichwörter der Autor:innen

HER2-negative breast cancerKi-67adjuvant therapy decision-makingearly-stage breast cancergenomic assayshormone receptor-positive breast canceroncotype DXrecurrence scoretumor proliferation

Autor:innen und Institutionen

  • Breast Division, Department of General Surgery, St. Luke's Hospital, Panorama, 55236 Thessaloniki, Greece.
  • Genekor Medical S.A., 15344 Athens, Greece.
  • Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • Second Breast Clinic, General Maternity and Gynecology Clinic, IASO General Hospital, 15123 Athens, Greece.
  • Second Department of Surgical Oncology, General Anticancer and Oncology Hospital of Athens "Agios Savvas", Alexandras Avenue 171, 11522 Athens, Greece.
  • First Breast Clinic, General Maternity and Gynecology Clinic, IASO General Hospital, 15123 Athens, Greece.

ORCID-Profile: Konstantinos Louis, Xenophon Xenakis, Anna Sachoulidou, Ioannis P Fyssas, Maria Matiatou, Panagiotis Karathanasis, Dimitrios Alexandrou, Eleni Efraimidou

Zitieren

APA

Dragoumis, D., Kapetsis, G., Louis, K., Maniatis, D., Mpalampou, E., Bouloukos, K., Xenakis, X., Papaioannou, N., Parpoudi, S., Pesmatzoglou, G., Sachoulidou, A., Sfakianakis, E., Triantafyllidou, S., Tsantilas, V., Tsiftsoglou, A., Filippidou, S., Fyssas, I. P., Stathoulopoulou, M., Matiatou, M., …, & Venizelos, V. (2026). Evaluating the Association of Ki-67 with Oncotype DX Recurrence Score in Early-Stage ER-Positive/HER2-Negative Breast Cancer. Cancers, 18(11), 1731. https://doi.org/10.3390/cancers18111731

Vancouver

Dragoumis D, Kapetsis G, Louis K, Maniatis D, Mpalampou E, Bouloukos K, et al. Evaluating the Association of Ki-67 with Oncotype DX Recurrence Score in Early-Stage ER-Positive/HER2-Negative Breast Cancer. Cancers. 2026;18(11):1731. doi:10.3390/cancers18111731

BibTeX
@article{Dragoumis2026,
  author = {Dragoumis, Dimitrios and Kapetsis, George and Louis, Konstantinos and Maniatis, Dimitrios and Mpalampou, Eleni and Bouloukos, Konstantinos and Xenakis, Xenophon and Papaioannou, Nikolaos and Parpoudi, Styliani and Pesmatzoglou, Grigorios and Sachoulidou, Anna and Sfakianakis, Eleftherios and Triantafyllidou, Sofia and Tsantilas, Vlasios and Tsiftsoglou, Aris and Filippidou, Sofia and Fyssas, Ioannis P and Stathoulopoulou, Maroulio and Matiatou, Maria and Karathanasis, Panagiotis and Alexandrou, Dimitrios and Amanatidou, Anastasia and Desiris, Klearchos and Efraimidou, Eleni and Zavos, Apostolos and Michailidou, Evropi and Roussogiannis, Sotirios and Venizelos, Vasileios},
  title = {Evaluating the Association of Ki-67 with Oncotype DX Recurrence Score in Early-Stage ER-Positive/HER2-Negative Breast Cancer},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1731},
  doi = {10.3390/cancers18111731}
}
Kostenlos starten →